GC PHARMAS HUNTERASE TO TREAT HUNTER SYNDROME FINDS NEW ALLY IN CHINA

• GC Pharma’s discovery, Hunterase for treatment of Hunter syndrome has been approved by the Chinese drug authority, the company said Wednesday.
• Hunterase is suggested for long-term treatment of Hunter syndrome, and is the first of its kind to be officially approved for use by China’s National Medical Products Administration.

CAN Bridge Pharmaceuticals is the agency that has been given the....